{
    "2018-06-21": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Novo Nordisk's (NVO) Oral Ozempic Positive in Diabetes Study",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Oral Ozempic",
                        "Positive",
                        "Diabetes",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug Makers Equities",
                "features": {
                    "keywords": [
                        "Initiating",
                        "Research Reports",
                        "Bristol-Myers Squibb",
                        "Drug Makers",
                        "Equities"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}